89 related articles for article (PubMed ID: 17551386)
21. The two faces of the 15-lipoxygenase in atherosclerosis.
Wittwer J; Hersberger M
Prostaglandins Leukot Essent Fatty Acids; 2007 Aug; 77(2):67-77. PubMed ID: 17869078
[TBL] [Abstract][Full Text] [Related]
22. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
[TBL] [Abstract][Full Text] [Related]
23. Immune responses against fibronectin modified by lipoprotein oxidation and their association with cardiovascular disease.
Dunér P; To F; Alm R; Gonçalves I; Fredrikson GN; Hedblad B; Berglund G; Nilsson J; Bengtsson E
J Intern Med; 2009 May; 265(5):593-603. PubMed ID: 19226376
[TBL] [Abstract][Full Text] [Related]
24. Inflammation and immunity in diabetic vascular complications.
Nilsson J; Bengtsson E; Fredrikson GN; Björkbacka H
Curr Opin Lipidol; 2008 Oct; 19(5):519-24. PubMed ID: 18769234
[TBL] [Abstract][Full Text] [Related]
25. Atherosclerosis in ANCA-associated vasculitides.
Pagnoux C; Chironi G; Simon A; Guillevin L
Ann N Y Acad Sci; 2007 Jun; 1107():11-21. PubMed ID: 17804528
[TBL] [Abstract][Full Text] [Related]
26. Oxidized to non-oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patients.
Girona J; Manzanares JM; Marimón F; Cabré A; Heras M; Guardiola M; Ribalta J; Masana L
Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):380-7. PubMed ID: 17904830
[TBL] [Abstract][Full Text] [Related]
27. Toll-like receptors in atherosclerosis.
Tobias PS; Curtiss LK
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1453-5. PubMed ID: 18031244
[TBL] [Abstract][Full Text] [Related]
28. HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis.
Zerrad-Saadi A; Therond P; Chantepie S; Couturier M; Rye KA; Chapman MJ; Kontush A
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2169-75. PubMed ID: 19762782
[TBL] [Abstract][Full Text] [Related]
29. Influence of CD4+/CD25+ regulatory T cells on atherogenesis in patients with end-stage kidney disease.
Meier P; Meier R; Blanc E
Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):987-97. PubMed ID: 18666849
[TBL] [Abstract][Full Text] [Related]
30. Chronic inflammatory autoimmune disorders and atherosclerosis.
Abou-Raya S; Abou-Raya A; Naim A; Abuelkheir H
Ann N Y Acad Sci; 2007 Jun; 1107():56-67. PubMed ID: 17804533
[TBL] [Abstract][Full Text] [Related]
31. Natural antibodies against phosphorylcholine in cardiovascular disease.
de Faire U; Frostegård J
Ann N Y Acad Sci; 2009 Sep; 1173():292-300. PubMed ID: 19758165
[TBL] [Abstract][Full Text] [Related]
32. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
[TBL] [Abstract][Full Text] [Related]
33. Innate immunity, macrophage activation, and atherosclerosis.
Yan ZQ; Hansson GK
Immunol Rev; 2007 Oct; 219():187-203. PubMed ID: 17850490
[TBL] [Abstract][Full Text] [Related]
34. Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice.
Shiraishi Y; Watanabe T; Suguro T; Nagashima M; Kato R; Hongo S; Itabe H; Miyazaki A; Hirano T; Adachi M
J Hypertens; 2008 Oct; 26(10):1955-65. PubMed ID: 18806619
[TBL] [Abstract][Full Text] [Related]
35. 'Multipurpose oxidase' in atherogenesis.
Rader DJ; Ischiropoulos H
Nat Med; 2007 Oct; 13(10):1146-7. PubMed ID: 17917660
[No Abstract] [Full Text] [Related]
36. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.
Kerekes G; Szekanecz Z; Dér H; Sándor Z; Lakos G; Muszbek L; Csipö I; Sipka S; Seres I; Paragh G; Kappelmayer J; Szomják E; Veres K; Szegedi G; Shoenfeld Y; Soltész P
J Rheumatol; 2008 Mar; 35(3):398-406. PubMed ID: 18203326
[TBL] [Abstract][Full Text] [Related]
37. The fine-tuning of anti-oxidized low-density lipoprotein antibodies in cardiovascular disease and thrombosis.
Freire de Carvalho J; Sherer Y; Shoenfeld Y
Thromb Haemost; 2007 Dec; 98(6):1157-9. PubMed ID: 18064307
[TBL] [Abstract][Full Text] [Related]
38. [Autoimmune and inflammatory mechanisms of atherosclerosis development].
Nagornev VA; Mal'tseva SV
Arkh Patol; 2005; 67(5):6-15. PubMed ID: 16323472
[TBL] [Abstract][Full Text] [Related]
39. Adaptive immunity in atherogenesis: new insights and therapeutic approaches.
Lichtman AH; Binder CJ; Tsimikas S; Witztum JL
J Clin Invest; 2013 Jan; 123(1):27-36. PubMed ID: 23281407
[TBL] [Abstract][Full Text] [Related]
40. Inflammatory and autoimmune mechanisms in the induction of atherosclerotic damage in systemic rheumatic diseases: two faces of the same coin.
Bartoloni E; Shoenfeld Y; Gerli R
Arthritis Care Res (Hoboken); 2011 Feb; 63(2):178-83. PubMed ID: 20740611
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
